公司概覽
業務類別 Drug Manufacturers - Specialty & Generic
業務概覽 Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.
公司地址 1 Burlington Road, Connaught House, Dublin, IRL, D04 C5Y6
電話號碼 +353 17728000
傳真號碼 --
公司網頁 https://www.alkermes.com
員工數量 2050
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Richard F. Pops Chairman of the Board and Chief Executive Officer 美元 1.21M 25/02/2026
Mr. Joshua Reed Senior Vice President and Chief Financial Officer -- 25/02/2026
Mr. Samuel J. Parisi Interim Principal Accounting Officer; Vice President, Finance of Alkermes, Inc. -- 25/02/2026
Mr. Iain M. Brown Senior Vice President, Chief Financial Officer and Principal Accounting Officer 美元 256.72K 05/02/2024
Mr. David Joseph Gaffin Executive Vice President, Chief Legal Officer, Secretary and Chief Compliance Officer 美元 664.56K 07/04/2025
Dr. Craig C. Hopkinson, M.D. Executive Vice President, Research and Development and Chief Medical Officer 美元 742.56K 07/04/2025
Mr. Christian Todd Nichols Senior Vice President and Chief Commercial Officer 美元 596.96K 07/04/2025
Mr. Blair C. Jackson Executive Vice President and Chief Operating Officer 美元 715.00K 25/02/2026
 
董事會成員
董事會 職務 更新日期
Mr. Brian P. Mckeon Independent Director 25/02/2026
Dr. Cato T. Laurencin,M.D.,PhD Independent Director 25/02/2026
Mr. Richard F. Pops Chairman of the Board and Chief Executive Officer 25/02/2026
Mr. Frank Anders Wilson Lead Independent Director 25/02/2026
Mr. Shane M. Cooke Independent Director; Chairman of the Board of Alkermes Pharma Ireland Limited 25/02/2026
Ms. Nancy S. Lurker Independent Director 25/02/2026
Dr. Nancy L. Snyderman, F.A.C.S.,M.D. Independent Director 25/02/2026
Dr. Richard Brian Gaynor, M.D. Independent Director 25/02/2026
Dr. Christopher I. Wright, M.D.,PhD Independent Director 25/02/2026
 
所屬ETF (更新日期: 07/03/2026 04:29)
代號 名稱 佔比% 持有日期
SMIZZacks Small/Mid Cap ETF0.02%27/02/2026
DFAUDimensional US Core Equity Market ETF0.02%27/02/2026
JPSEJPMorgan Divers Ret US Small Cap Eq ETF0.02%27/02/2026
SPTMState StreetSPDRPortS&P1500CompStkMktETF0.02%27/02/2026
FNKFirst Trust Mid Cap Value AlphaDEX® ETF0.02%26/02/2026
VTWVVanguard Russell 2000 Value ETF0.02%31/01/2026
QVMSInvesco S&P SmallCp 600 QVM Mlt-fctr ETF0.02%27/02/2026
SEISSEI Select Small Cap ETF0.02%27/02/2026
ISCGiShares Morningstar Small-Cap Growth ETF0.01%28/02/2026
TPSCTimothy Plan US Small Cap Core ETF0.01%27/02/2026
ROUSHartford Multifactor US Equity ETF0.01%28/02/2026
KNOAXS Knowledge Leaders ETF0.01%27/02/2026
VALQAmerican Century® U.S. Quality Value ETF0.01%28/02/2026
RZGInvesco S&P SmallCap 600® Pure Gr ETF0.01%27/02/2026
FLQSFranklin US Small Cap Mltfctr Idx ETF0.01%28/02/2026
XJRiShares ESG Select Scrn S&P Small-CapETF0.01%28/02/2026
VFVAVanguard US Value Factor ETF0.01%31/12/2025
VTHRVanguard Russell 3000 ETF0.01%31/01/2026
PDNInvesco RAFI Developed Mkts ex-US S-METF0.01%24/02/2026
DCORDimensional US Core Equity 1 ETF0.01%27/02/2026
  1    2    3   4    5    6    7    8  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.